InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Donley Matthew Maxwell, Vice-Président Exécutif. Insider active across 1 companies, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 3 filings have been recorded. Total volume traded: €164k. The latest transaction was disclosed on 2 March 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations3 total
08,500 shares0
Common Stock
SEC:0001628280-22-005129:0·
€82,1279,900 shares@ €8.2956100.0% of flow
Common Stock
SEC:0001628280-21-010023·
Ideal exit: 5 Feb 2022 (T+270)
€82,1279,900 shares@ €8.29560.0039% mcap50.0% of flow
Common Stock
SEC:0001628280-21-010023:0·
Ideal exit: 5 Feb 2022 (T+270)
3 of 3 declarations
About Donley Matthew Maxwell
Matthew Maxwell Donley is the Executive Vice President of International Operations at Aurinia Pharmaceuticals Inc. In this role, he oversees international operations and contributes to the company's strategy. His experience in the pharmaceutical sector allows him to provide valuable insights on innovation and research. He is committed to supporting growth initiatives.
